Pacira BioSciences Files Q1 2025 10-Q
Ticker: PCRX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Pacira BioSciences Q1 2025 10-Q is in. Check product revenue & royalties vs last year.
AI Summary
Pacira BioSciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations, including product revenue and royalty income for the first quarter of 2025 compared to the same period in 2024. The company is based in Brisbane, CA.
Why It Matters
This filing provides investors with an update on Pacira BioSciences' financial health and operational performance for the first quarter of 2025, crucial for assessing investment value.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Pacira BioSciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q1 2025 — Reporting Period (First quarter financial results)
- Q1 2024 — Prior Period (Comparison period for financial results)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
- Brisbane, CA (location) — Company headquarters
FAQ
What were Pacira BioSciences' product revenues for the first quarter of 2025?
The filing indicates product revenue for the period from January 1, 2025, to March 31, 2025, but the specific dollar amount is not detailed in this header information.
How did royalty income in Q1 2025 compare to Q1 2024?
The filing includes data for royalty income for both Q1 2025 and Q1 2024, suggesting a comparison is available within the full document.
What is Pacira BioSciences' fiscal year end?
Pacira BioSciences' fiscal year ends on December 31.
When was Pacira BioSciences, Inc. formerly known as Pacira Pharmaceuticals, Inc.?
The company changed its name from Pacira Pharmaceuticals, Inc. on October 29, 2010.
What is the SEC file number for Pacira BioSciences?
The SEC file number for Pacira BioSciences is 001-35060.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Pacira BioSciences, Inc. (PCRX).